KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Vir Biotechnology (VIR) Revenue (2018 - 2025)

Vir Biotechnology's Revenue history spans 8 years, with the latest figure at $64.1 million for Q4 2025.

  • On a quarterly basis, Revenue rose 417.78% to $64.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $68.6 million, a 1.4% decrease, with the full-year FY2025 number at $68.6 million, down 7.61% from a year prior.
  • Revenue hit $64.1 million in Q4 2025 for Vir Biotechnology, up from $240000.0 in the prior quarter.
  • Over the last five years, Revenue for VIR hit a ceiling of $1.2 billion in Q1 2022 and a floor of $240000.0 in Q3 2025.
  • Historically, Revenue has averaged $150.4 million across 5 years, with a median of $28.7 million in 2022.
  • Biggest five-year swings in Revenue: soared 62271.41% in 2022 and later crashed 99.3% in 2023.
  • Tracing VIR's Revenue over 5 years: stood at $812.7 million in 2021, then plummeted by 93.92% to $49.4 million in 2022, then plummeted by 66.03% to $16.8 million in 2023, then fell by 26.29% to $12.4 million in 2024, then skyrocketed by 417.78% to $64.1 million in 2025.
  • Business Quant data shows Revenue for VIR at $64.1 million in Q4 2025, $240000.0 in Q3 2025, and $1.2 million in Q2 2025.